Allarity Therapeutics is advancing its drug approval process, supported by AACR data and a new USPTO patent.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• American Association for Cancer Research →

  scientific society

  • The American Association for Cancer Research (AACR) conference is being held in San Diego.Mon 13:07
  • The African Democratic Congress (ADC) made progress and was highlighted at the American Association for Cancer Research (AACR) conference.Fri 14:00

Related events

• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• Nkarta is seeking protocol amendments for its clinical trials under the FDA.Sun 19:56
• Experimental therapies require approval from the FDA.Sep 21
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.Sep 2